Document is current
Any future updates will be listed below
-
Authors
Caughey, Bennett A. https://orcid.org/0000-0002-3970-1651
Strickler, John H. https://orcid.org/0000-0001-7579-1175
- License Information
-
More Information
Article History
Accepted: 21 November 2023
First Online: 18 December 2023
Declarations
:
: No external funding was received for the preparation of this article.
: Bennett A. Caughey has received honoraria from Foundation Medicine, Inc. John H. Strickler has received grant/research support from AbbVie, Amgen, AStar D3, Bayer, Beigene, Curegenix, Daiichi-Sankyo, Eli Lilly, Erasca, Gossamer Bio, Leap Therapeutics, Nektar, Roche/Genentech, Seagen, and Silverback Therapeutics; and consulting fees from or serving in an advisory role to AbbVie, Amgen, AstraZeneca, Bayer, Beigene, Daiichi-Sankyo, Eli Lilly, G3 Therapeutics, GSK, Natera, Pfizer, Pionyr Immunotherapeutics, Roche/Genentech, Seagen, Silverback Therapeutics, Takeda, and Viatris.
: Not applicable.
: Not applicable.
: Not applicable.
: All data were derived from publicly available sources at Project Genie Public Cohort 13.1, available at genie.cbioportal.org.
: Not applicable.
: BAC and JHS both contributed to all areas of the manuscript, including conception and design, assembly and collection of data, and manuscript writing. Both authors gave final approval to the manuscript.
